vs
Hillenbrand, Inc.（HI）与VirTra, Inc（VTSI）财务数据对比。点击上方公司名可切换其他公司
Hillenbrand, Inc.的季度营收约是VirTra, Inc的188.9倍（$550.2M vs $2.9M）。Hillenbrand, Inc.净利率更高（-0.4% vs -27.2%，领先26.8%）。Hillenbrand, Inc.同比增速更快（-22.2% vs -46.5%）。VirTra, Inc自由现金流更多（$-2.1M vs $-31.6M）。过去两年Hillenbrand, Inc.的营收复合增速更高（-16.3% vs -37.0%）
希伦布兰德是一家全球化多元化工业企业，设计、生产及销售专用加工设备与耐用工业解决方案，服务食品饮料、农业、制造、废弃物管理等领域，业务覆盖北美、欧洲及亚太地区。
VirTra Inc是全球沉浸式训练模拟器及配套课程供应商，主要服务执法机构、军事单位及公共安全组织，提供场景化训练系统，帮助一线人员提升决策能力、降级处置技巧与作业安全水平。
HI vs VTSI — 直观对比
营收规模更大
HI
是对方的188.9倍
$2.9M
营收增速更快
HI
高出24.3%
-46.5%
净利率更高
HI
高出26.8%
-27.2%
自由现金流更多
VTSI
多$29.5M
$-31.6M
两年增速更快
HI
近两年复合增速
-37.0%
损益表 — Q1 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $550.2M | $2.9M |
| 净利润 | $-2.2M | $-792.4K |
| 毛利率 | 33.4% | 57.5% |
| 营业利润率 | -2.2% | -47.9% |
| 净利率 | -0.4% | -27.2% |
| 营收同比 | -22.2% | -46.5% |
| 净利润同比 | -134.4% | 10.8% |
| 每股收益（稀释后） | — | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HIVTSI
| Q4 25 | $550.2M | $2.9M | ||
| Q3 25 | $652.1M | $5.3M | ||
| Q2 25 | $598.9M | $7.0M | ||
| Q1 25 | $715.9M | $7.2M | ||
| Q4 24 | $706.9M | $5.4M | ||
| Q3 24 | $837.6M | $7.5M | ||
| Q2 24 | $786.6M | $6.1M | ||
| Q1 24 | $785.3M | $7.3M |
净利润HIVTSI
| Q4 25 | $-2.2M | $-792.4K | ||
| Q3 25 | $75.7M | $-388.6K | ||
| Q2 25 | $1.9M | $175.3K | ||
| Q1 25 | $-40.9M | $1.3M | ||
| Q4 24 | $6.4M | $-888.3K | ||
| Q3 24 | $14.6M | $583.1K | ||
| Q2 24 | $-248.9M | $1.2M | ||
| Q1 24 | $6.1M | $468.2K |
毛利率HIVTSI
| Q4 25 | 33.4% | 57.5% | ||
| Q3 25 | 34.8% | 65.8% | ||
| Q2 25 | 33.8% | 69.0% | ||
| Q1 25 | 33.0% | 72.6% | ||
| Q4 24 | 33.2% | 67.5% | ||
| Q3 24 | 34.4% | 73.5% | ||
| Q2 24 | 33.9% | 90.9% | ||
| Q1 24 | 31.9% | 64.2% |
营业利润率HIVTSI
| Q4 25 | -2.2% | -47.9% | ||
| Q3 25 | — | -8.4% | ||
| Q2 25 | 1.8% | 13.1% | ||
| Q1 25 | -6.2% | 19.1% | ||
| Q4 24 | 2.2% | -9.9% | ||
| Q3 24 | — | 10.1% | ||
| Q2 24 | -32.7% | 18.6% | ||
| Q1 24 | 1.6% | 8.9% |
净利率HIVTSI
| Q4 25 | -0.4% | -27.2% | ||
| Q3 25 | 11.6% | -7.3% | ||
| Q2 25 | 0.3% | 2.5% | ||
| Q1 25 | -5.7% | 17.7% | ||
| Q4 24 | 0.9% | -16.3% | ||
| Q3 24 | 1.7% | 7.8% | ||
| Q2 24 | -31.6% | 19.8% | ||
| Q1 24 | 0.8% | 6.4% |
每股收益（稀释后）HIVTSI
| Q4 25 | — | $-0.08 | ||
| Q3 25 | $1.07 | $-0.03 | ||
| Q2 25 | $0.03 | $0.02 | ||
| Q1 25 | $-0.58 | $0.11 | ||
| Q4 24 | $0.09 | $-0.08 | ||
| Q3 24 | $0.20 | $0.05 | ||
| Q2 24 | $-3.53 | $0.11 | ||
| Q1 24 | $0.09 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $173.1M | $18.6M |
| 总债务越低越好 | — | $7.5M |
| 股东权益账面价值 | $1.4B | $45.6M |
| 总资产 | $4.5B | $65.1M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资HIVTSI
| Q4 25 | $173.1M | $18.6M | ||
| Q3 25 | $164.8M | $20.8M | ||
| Q2 25 | $162.8M | $20.7M | ||
| Q1 25 | $458.4M | $17.6M | ||
| Q4 24 | $208.0M | $18.0M | ||
| Q3 24 | $199.3M | $19.7M | ||
| Q2 24 | $223.8M | $18.4M | ||
| Q1 24 | $224.4M | $22.4M |
总债务HIVTSI
| Q4 25 | — | $7.5M | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $1.9B | — | ||
| Q4 24 | $1.9B | $7.8M | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $2.1B | — | ||
| Q1 24 | $2.1B | — |
股东权益HIVTSI
| Q4 25 | $1.4B | $45.6M | ||
| Q3 25 | $1.4B | $46.3M | ||
| Q2 25 | $1.3B | $46.8M | ||
| Q1 25 | $1.3B | $46.5M | ||
| Q4 24 | $1.4B | $45.2M | ||
| Q3 24 | $1.4B | $45.7M | ||
| Q2 24 | $1.4B | $44.9M | ||
| Q1 24 | $1.7B | $43.5M |
总资产HIVTSI
| Q4 25 | $4.5B | $65.1M | ||
| Q3 25 | $4.5B | $66.2M | ||
| Q2 25 | $4.7B | $67.4M | ||
| Q1 25 | $4.8B | $66.8M | ||
| Q4 24 | $5.1B | $65.0M | ||
| Q3 24 | $5.2B | $66.1M | ||
| Q2 24 | $5.3B | $66.0M | ||
| Q1 24 | $5.6B | $69.4M |
负债/权益比HIVTSI
| Q4 25 | — | 0.17× | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 1.27× | — | ||
| Q1 25 | 1.44× | — | ||
| Q4 24 | 1.38× | 0.17× | ||
| Q3 24 | 1.33× | — | ||
| Q2 24 | 1.48× | — | ||
| Q1 24 | 1.28× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-27.4M | $-1.5M |
| 自由现金流经营现金流 - 资本支出 | $-31.6M | $-2.1M |
| 自由现金流率自由现金流/营收 | -5.7% | -72.5% |
| 资本支出强度资本支出/营收 | 0.8% | 21.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $7.8M | $2.9M |
8季度趋势，按日历期对齐
经营现金流HIVTSI
| Q4 25 | $-27.4M | $-1.5M | ||
| Q3 25 | $67.7M | $36.3K | ||
| Q2 25 | $-1.5M | $6.0M | ||
| Q1 25 | $1.3M | $65.7K | ||
| Q4 24 | $-11.3M | $-908.7K | ||
| Q3 24 | $166.5M | $897.7K | ||
| Q2 24 | $45.6M | $-3.9M | ||
| Q1 24 | $3.2M | $5.1M |
自由现金流HIVTSI
| Q4 25 | $-31.6M | $-2.1M | ||
| Q3 25 | $58.6M | $-61.2K | ||
| Q2 25 | $-11.2M | $5.4M | ||
| Q1 25 | $-8.0M | $-362.7K | ||
| Q4 24 | $-21.5M | $-1.1M | ||
| Q3 24 | $153.4M | $814.2K | ||
| Q2 24 | $29.7M | $-3.9M | ||
| Q1 24 | $-9.6M | $3.6M |
自由现金流率HIVTSI
| Q4 25 | -5.7% | -72.5% | ||
| Q3 25 | 9.0% | -1.1% | ||
| Q2 25 | -1.9% | 77.6% | ||
| Q1 25 | -1.1% | -5.1% | ||
| Q4 24 | -3.0% | -19.5% | ||
| Q3 24 | 18.3% | 10.9% | ||
| Q2 24 | 3.8% | -64.7% | ||
| Q1 24 | -1.2% | 48.9% |
资本支出强度HIVTSI
| Q4 25 | 0.8% | 21.2% | ||
| Q3 25 | 1.4% | 1.8% | ||
| Q2 25 | 1.6% | 8.1% | ||
| Q1 25 | 1.3% | 6.0% | ||
| Q4 24 | 1.4% | 2.8% | ||
| Q3 24 | 1.6% | 1.1% | ||
| Q2 24 | 2.0% | 1.0% | ||
| Q1 24 | 1.6% | 21.1% |
现金转化率HIVTSI
| Q4 25 | — | — | ||
| Q3 25 | 0.89× | — | ||
| Q2 25 | -0.79× | 34.12× | ||
| Q1 25 | — | 0.05× | ||
| Q4 24 | -1.77× | — | ||
| Q3 24 | 11.40× | 1.54× | ||
| Q2 24 | — | -3.22× | ||
| Q1 24 | 0.52× | 10.97× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HI
| Transferred At Point In Time | $256.5M | 47% |
| Transferred Over Time | $207.1M | 38% |
| Molding Technology Solutions | $86.6M | 16% |
VTSI
暂无分部数据
